250 related articles for article (PubMed ID: 20650633)
1. Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening.
Geldenhuys WJ; Darvesh AS; Funk MO; Van der Schyf CJ; Carroll RT
Bioorg Med Chem Lett; 2010 Sep; 20(17):5295-8. PubMed ID: 20650633
[TBL] [Abstract][Full Text] [Related]
2. A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.
Geldenhuys WJ; Funk MO; Van der Schyf CJ; Carroll RT
Bioorg Med Chem Lett; 2012 Feb; 22(3):1380-3. PubMed ID: 22225638
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
4. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
Legoabe LJ; Petzer A; Petzer JP
Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
Khalil AA; Davies B; Castagnoli N
Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
[TBL] [Abstract][Full Text] [Related]
7. Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation.
Mishra N; Sasmal D
Bioorg Med Chem Lett; 2011 Apr; 21(7):1969-73. PubMed ID: 21377879
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Prins LH; Petzer JP; Malan SF
Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
[TBL] [Abstract][Full Text] [Related]
9. Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.
Toprakçí M; Yelekçi K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4438-46. PubMed ID: 16137882
[TBL] [Abstract][Full Text] [Related]
10. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Lourens AC; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Dec; 22(24):7367-70. PubMed ID: 23122857
[TBL] [Abstract][Full Text] [Related]
11. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors.
Shi L; Yang Y; Li ZL; Zhu ZW; Liu CH; Zhu HL
Bioorg Med Chem; 2010 Feb; 18(4):1659-64. PubMed ID: 20117937
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking of inhibitors into monoamine oxidase B.
Harkcom WT; Bevan DR
Biochem Biophys Res Commun; 2007 Aug; 360(2):401-6. PubMed ID: 17597580
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening.
Novaroli L; Reist M; Favre E; Carotti A; Catto M; Carrupt PA
Bioorg Med Chem; 2005 Nov; 13(22):6212-7. PubMed ID: 16054369
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
Manley-King CI; Bergh JJ; Petzer JP
Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.
Strydom B; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2010 Feb; 18(3):1018-28. PubMed ID: 20093036
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC).
Vlok N; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2006 May; 14(10):3512-21. PubMed ID: 16442801
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cardia MC; Distinto S
J Med Chem; 2007 Feb; 50(4):707-12. PubMed ID: 17253676
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Santana L; González-Díaz H; Quezada E; Uriarte E; Yáñez M; Viña D; Orallo F
J Med Chem; 2008 Nov; 51(21):6740-51. PubMed ID: 18834112
[TBL] [Abstract][Full Text] [Related]
20. Selected chromone derivatives as inhibitors of monoamine oxidase.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
